Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation

International Review of Psychiatry

Volumn 23, Issue 5, 2011, Pages 424-436

  Rizvi, Sakina J ^a,b   Donovan, Madelin ^a   Giacobbe, Peter ^a,b   Placenza, Franca ^a   Rotzinger, Susan ^a   Kennedy, Sidney H ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MONOAMINE; NORADRENALIN; SEROTONIN; SUBSTANCE P;

AGITATION; ANXIETY DISORDER; ARTICLE; BRAIN DEPTH STIMULATION; CELLULITIS; CINGULATE GYRUS; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CORPUS STRIATUM; DISEASE MODEL; DIZZINESS; DORSAL RAPHE NUCLEUS; DRUG TREATMENT FAILURE; DYSPHAGIA; DYSPNEA; ELECTROCONVULSIVE THERAPY; EPILEPSY; ERYTHEMA; EYE EDEMA; HABENULA; HEADACHE; HOARSENESS; HUMAN; HYPERHIDROSIS; HYPOMANIA; IMMUNE SYSTEM; INFERIOR THALAMIC PEDUNCLE; INFORMATION PROCESSING; LATERAL HABENULA; LOCUS CERULEUS; NAUSEA; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NONHUMAN; NUCLEUS ACCUMBENS; PAIN; PATIENT SAFETY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCALLOSAL CINGULATE GYRUS; SUICIDAL IDEATION; SYNCOPE; THALAMUS; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; TREMOR; VAGUS NERVE STIMULATION; VOICE CHANGE;

ANTIDEPRESSIVE AGENTS; BRAIN; COMBINED MODALITY THERAPY; COST OF ILLNESS; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DEVICE APPROVAL; HUMANS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; THERAPIES, INVESTIGATIONAL; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84855246307     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2011.630993     Document Type: Article

References (96)

1. Bajbouj M., Merkl A., Schlaepfer T.E., Frick C., Zobel A., Maier W., ⋯Heuser I. (2010). Two-year outcome of vagus nerve stimulation in treatment-resistant depression. Journal of Clinical Psychopharmacology, 30, 273-281.
2. Benabid A.L. (2007). What the future holds for deep brain stimulation. Expert Review of Medical Devices, 4 , 895-903.
3. Bewernick B.H., Hurlemann R., Matusch A., Kayser S., Grubert C., Hadrysiewicz B., Schlaepfer T.E. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry, 67 , 110-116.
4. Biggio F., Gorini G., Utzeri C., Olla P., Marrosu F., Mocchetti I. & Follesa P. (2009). Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. International Journal of Neuropsychopharmacology, 12, 1209-1221.
5. Blood A.J. & Zatorre R.J. (2001). Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion . Proceedings of the National Academy of Science of the United States of America, 98 , 11818-11823. (Pubitemid 32928812)
6. Bostwick J.M. & Pankratz V.S. (2000). Affective disorders and suicide risk: A reexamination. American Journal of Psychiatry, 157 , 1925-1932.
7. Capuron L., Raison C.L., Musselman D.L., Lawson D.H., Nemeroff C.B. & Miller A.H. (2003). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. American Journal of Psychiatry, 160, 1342-1345. (Pubitemid 41070955)
8. Carpenter L.L., Moreno F.A., Kling M.A., Anderson G.M., Regenold W.T., Labiner D.M. & Price L.H. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biological Psychiatry, 56 , 418-426. (Pubitemid 39195322)
9. Carpenter L.L., Bayat L., Moreno F., Kling M.A., Price L.H., Tyrka A.R. & Nemeroff C.B. (2008). Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Research, 157, 123-129. (Pubitemid 350167564)
10. Chae J.H., Nahas Z., Lomarev M., Denslow S., Lorberbaum J.P., Bohning D.E. & George M.S. (2003). A review of functional neuroimaging studies of vagus nerve stimulation (VNS). Journal of Psychiatric Research, 37, 443-455. (Pubitemid 37238938)
11. Connor T.J. & Leonard B.E. (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sciences, 62, 583-606.
12. Conway C.R., Sheline Y.I., Chibnall J.T., George M.S., Fletcher J.W. & Mintun M.A. (2006). Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research, 146 , 179-184.
13. Corcoran C., Connor T.J., O'Keane V. & Garland M.R. (2005). The effects of vagus nerve stimulation on pro-and antiinflammatory cytokines in humans: A preliminary report. Neuroimmunomodulation, 12, 307-309. (Pubitemid 41318214)
14. Cristancho P., Cristancho M.A., Baltuch G.H., Thase M.E. & O'Reardon J.P. (2011). Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: Outcomes at 1 year. Journal of Clinical Psychiatry, 72, 1376-1382.
15. Cryan J.F., Page M.E. & Lucki I. (2005). Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berlin), 182, 335-344. (Pubitemid 41464645)
16. Cunningham J.T., Mifflin S.W., Georgianna G.G. & Frazer A. (2008). Induction of c-Fos and i FosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology, 33 , 1884-1895. (Pubitemid 351832591)
17. De Herdt V., Bogaert S., Bracke K.R., Raedt R., De Vos M., Vonck K., Boon P. (2009). Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. Journal of Neuroimmunology, 214 :104-108.
18. Dorr A.E. & Debonnel G. (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. Journal of Pharmacology & Experimental Therapeutics, 318, 890-898. (Pubitemid 44061265)
19. Epstein J., Pan H., Kocsis J.H., Yang Y., Butler T., Chusid J., ⋯Silbersweig D.A. (2006). Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. American Journal of Psychiatry, 2006;163 :1784-1790. (Pubitemid 44522488)
20. Fava M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53, 649-659. (Pubitemid 39658481)
21. Geisler S. & Trimble M. (2008). The lateral habenula: No longer neglected. CNS Spectrums, 13 , 484-489. (Pubitemid 351960773)
22. George M.S., Rush A.J., Marangell L.B., Sackeim H.A., Brannan S.K. ⋯Goodnick P. (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment- resistant depression. Biological Psychiatry, 58, 364-373. (Pubitemid 41219704)
23. Gibson T.B., Jing Y., Smith Carls G., Kim E., Bagalman J.E., Burton W.N., ⋯Goetzel R.Z. (2010). Cost burden of treatment resistance in patients with depression. American Journal of Managed Care, 16, 370-377.
24. Greenberg B.D., Malone D.A., Friehs G.M., Rezai A.R., Kubu C.S., Malloy P.F., ⋯Rasmussen S.A. (2006). Threeyear outcomes in deep brain stimulation for highly resistant obsessive - compulsive disorder. Neuropsychopharmacology, 31 , 2384-2393. (Pubitemid 44607055)
25. Gutman D.A., Holtzheimer P.E., Behrens T.E., Johansen-Berg H. & Mayberg H.S. (2009). A tractography analysis of two deep brain stimulation white matter targets for depression. Biological Psychiatry, 65, 276-282.
26. Guze S.B. & Robins E. (1970). Suicide and primary affective disorders. British Journal of Psychiatry, 117, 437-438.
27. Hamani C., Mayberg H., Snyder B., Giacobbe P., Kennedy S. & Lozano A.M. (2009). Deep brain stimulation of the subcallosal cingulate gyrus for depression: Anatomical location of active contacts in clinical responders and a suggested guideline for targeting. Journal of Neurosurgery, 111 , 1209-1215.
28. Hamani C., Diwan M., Macedo C.E., Brandão M.L., Shumake J., Gonzalez-Lima F., Raymond R., ⋯Nobrega J.N. (2010a). Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biological Psychiatry, 67 , 117-124.
29. Hamani C., Diwan M., Isabella S., Lozano A.M. & Nobrega J.N. (2010b). Effects of different stimulation parameters on the antidepressant- like response of medial prefrontal cortex deep brain stimulation in rats. Journal of Psychiatric Research, 44 , 683-687.
30. Hammad T.A., Laughren T.P. & Racoosin J.A. (2006). Suicide rates in short-term randomized controlled trials of newer antidepressants. Journal of Clinical Psychopharmacology, 26, 203-207. (Pubitemid 43740348)
31. Handforth A., DeGiorgio C.M., Schachter S.C., Uthman B.M., Naritoku D.K., Tecoma E.S., ⋯Whelas J.W.(1998). Vagus nerve stimulation therapy for partial-onset seizures: A randomized active control trial. Neurology, 51 , 48-55.
32. Hasler G., Fromm S., Carlson P.J., Luckenbaugh D.A., Waldeck T., Geraci M., ⋯Drevets W.C. (2008). Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry, 65 , 521-531. (Pubitemid 351645048)
33. Hern á ndez M.E., Mendieta D., Mart í nez-Fong D., Lor í a F., Moreno J., Estrada I., ⋯Pav ó n L. (2008). Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. European Neuropsychopharmacology, 18 , 917-924.
34. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Subramanian G., Khan S.A. & Stensland M.D. (2010). Direct and indirect costs of employees with treatment-resistant and non-treatmentresistant major depressive disorder. Current Medical Research & Opinion, 26, 2475-2484.
35. Jim é nez F., Velasco F., Salin-Pascual R., Hern á ndez J.A., Velasco M., Criales J.L. & Nicolini H. (2005). A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery, 57 , 585-593.
36. Kennedy S.H. & Giacobbe P. (2007). Treatment resistant depression - Advances in somatic therapies. Annals of Clinical Psychiatry, 19, 279-287. (Pubitemid 350208805)
37. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S. & Mayberg H.S. (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry, 164 , 778-788. (Pubitemid 46808533)
38. Kennedy S.H., Milev R., Giacobbe P., Ramasubbu R., Lam R.W., Parikh S.V., ⋯Canadian Network for Mood and Anxiety Treatments (CANMAT). (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies . Journal of Affective Disorders, 117, S44 - 53.
39. Kennedy S.H., Giacobbe P., Rizvi S.J., Placenza F.M., Nishikawa Y., Mayberg H.S. & Lozano A.M. (2011). Deep brain stimulation for treatment-resistant depression: Follow-up after 3 to 6 years. American Journal of Psychiatry, 168 , 502-510.
40. Kosel M., Brockmann H., Frick C., Zobel A. & Schlaepfer T.E. (2011). Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Research, 191 , 153-159.
41. Konarski J.Z., Kennedy S.H., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S. & Mayberg H.S. (2009). Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry and Neuroscience, 34 , 175-180.
42. Krahl S.E., Senanayake S.S., Pekary A.E. & Sattin A. (2004). Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. Journal of Psychiatric Research, 38, 237-240. (Pubitemid 38299160)
43. Li M., Soczynska J.K. & Kennedy S.H. (2011a). Inflammatory biomarkers in depression: An opportunity for novel therapeutic interventions. Current Psychiatry Reports, 13 , 316-320.
44. Li B., Piriz J., Mirrione M., Chung C., Proulx C.D., Schulz D., ⋯Malinow R. (2011b). Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature, 470, 535-539.
45. Lipsman N., McIntyre R.S., Giacobbe P., Torres C., Kennedy S.H. & Lozano A.M. (2010). Neurosurgical treatment of bipolar depression: Defining treatment resistance and identifying surgical targets. Bipolar Disorders, 12, 691-701.
46. Lozano A.M., Dostrovsky J., Chen R. & Ashby P. (2002). Deep brain stimulation for Parkinson's disease: Disrupting the disruption. Lancet Neurology, 1, 225-231. (Pubitemid 37159184)
47. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C. & Kennedy S.H. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry, 64, 461-467.
48. Lozano A.M., Giacobbe P., Hamani C., Rizvi S., Kennedy S.H., Kolivakis T.T., ⋯Mayberg, HS. (2011). A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment resistant depression. Journal of Neurosurgery , DOI: 10.3171/2011.10.JNS102122.
49. Majoie H.J., Rijkers K., Berfelo M.W., Hulsman J.A., Myint A., Schwarz M. & Vles J.S. (2011). Vagus nerve stimulation in refractory epilepsy: Effects on pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation, 18 , 52-56.
50. Malhi G.S. & Berk M. (2007). Does dopamine dysfunction drive depression? Acta Psychiatrica Scandinavica Supplementum, 433, 116-124. (Pubitemid 46114846)
51. Malone D.A. Jr, Dougherty D.D., Rezai A.R., Carpenter L.L., Friehs G.M., Eskandar E.N., ⋯Greenberg B.D. (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biological Psychiatry, 65, 267-275.
52. Manta S., Dong J., Debonnel G. & Blier P. (2009a). Enhancement of function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. Journal of Psychiatry & Neuroscience, 24 , 272-280.
53. Manta S., Dong J., Debonnel G. & Blier P. (2009b). Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal raphe. European Neuropsychopharmacology, 19 , 250-255.
54. Marangell L.B., Rush A.J., George M.S., Sackeim H.A., Johnson C.R., Husain M.M., ⋯Lisanby S.H. (2002). Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes. Biological Psychiatry, 51, 280-287. (Pubitemid 34214993)
55. Marangell L.B., Suppes T., Zboyan H.A., Prashad S.J., Fischer G., Snow D., ⋯Allen J.C. (2008). A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. Journal of Clinical Psychiatry, 69, 183-189. (Pubitemid 351469260)
56. Matsumoto M. & Hikosaka O. (2007). Lateral habenula as a source of negative reward signals in dopamine neurons. Nature, 447, 1111-1115. (Pubitemid 47014424)
57. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., ⋯Fox, PT. (1999). Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. American Journal of Psychiatry, 156 , 675-682. (Pubitemid 29220063)
58. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., ⋯Kennedy S.H. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45 , 651-660. (Pubitemid 40320700)
59. McCracken C.B. & Grace A.A. (2007). High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. Journal of Neuroscience, 27 , 12601-12610. (Pubitemid 350127827)
60. McCracken C.B. & Grace A.A. (2009). Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. Journal of Neuroscience, 29, 5354-5363.
61. Miller A.H., Maletic V. & Raison C.L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65 , 732-741.
62. Morris J.S., Smith K.A., Cowen P.J., Friston K.J. & Dolan R.J. (1999). Covariation of activity in habenula and dorsal raph é nuclei following tryptophan depletion. Neuroimage, 10 , 163-172. (Pubitemid 29379014)
63. Mussap C.J., Geraghty D.P. & Burcher E. (1993). Tachykinin receptors: A radioligand binding perspective. Journal of Neurochemistry, 60, 1987-2009. (Pubitemid 23148771)
64. Nahas Z., Marangell L.B., Husain M.M., Rush A.J., Sackeim H.A., Lisanby S.H., ⋯George, MS. (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry, 66 , 1097-1104. (Pubitemid 41442274)
65. Nemeroff C.B., Mayberg H.S., Krahl S.E., McNamara J., Frazer A., Henry T.R., ⋯Brannan S.K. (2006). VNS therapy in treatment- resistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology, 31 , 1345-1355.
66. Nierenberg A.A., Alpert J.E., Gardner-Schuster E.E., Seay S. & Mischoulon D. (2008). Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biological Psychiatry, 64 , 455-460.
67. Nowak L.G. & Bullier J. (1998). Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Expert Brain Research, 118 , 489-500.
68. Nuttin B., Cosyns P., Demeulemeester H., Gybels J. & Meyerson B. (1999). Electrical stimulation in anterior limbs of internal capsules in patients with obsessive - compulsive disorder. Lancet, 354 , 1526. (Pubitemid 29502111)
69. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V. & Dinan T.G. (2007). Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. Journal of Psychiatric Research, 41 , 326-331. (Pubitemid 44854992)
70. Pardo J.V., Sheikh S.A., Schwindt G.C., Lee J.T., Kuskowski M.A., Surerus C., ⋯Rittberg B.R. (2008). Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. Neuroimage, 42 , 879-889.
71. Pizzagalli D.A., Iosifescu D., Hallett L.A., Ratner K.G. & Fava M. (2008). Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task. Journal of Psychiatric Research, 43, 76-87.
72. Puigdemont D., Pérez-Egea R., Portella M.J., Molet J., de Diego-Adeliño J., Gironell A., ⋯P é rez V. (2011). Deep brain stimulation of the subcallosal cingulate gyrus: Further evidence in treatment-resistant major depression. International Journal of Neuropsychopharmacology, 2011, 22 :1-13.
73. Ranft K., Dobrowolny H., Krell D., Bielau H., Bogerts B. & Bernstein H.G. (2010). Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia. Psychological Medicine, 40 , 557-567.
74. Rauch S.L. (2003). Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurgery Clinics of North America, 14 , 213-223. (Pubitemid 36514461)
75. Rawlins P. (1997). Are there benefits, in addition to improved seizure control, for children receiving vagus nerve stimulation? Epilepsia,38S8 , S155 - 156.
76. Ressler K.J. & Mayberg H.S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nature Neuroscience, 10 , 1116-1124. (Pubitemid 47339944)
77. Revesz D., Tjernstrom M., Ben-Menachem E. & Thorlin T. (2008). Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Expert Neurology, 214 , 259-265.
78. Rizvi S.J., Kennedy S.H., Giacobbe P., Mayberg H.S. & Lozano A.M. (2011). Subcallosal cingualte gyrus deep brain stimulation for refractory major depressive disorder: Difference in FDG-PET between responders and non-responders. Biological Psychiatry, 69S9 , S173.
79. Rush A.J., George M.S., Sackeim H.A., Marangell L.B., Husain M.M., Giller C., ⋯Goodman R. (2000). Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biological Psychiatry, 47 , 276-286. (Pubitemid 30109240)
80. Rush A.J., Marangell L.B., Sackeim H.A., George M.S., Brannan S.K., Davis S.M., ⋯Cooke R.G. (2005). Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biological Psychiatry, 58 , 347-354. (Pubitemid 41219702)
81. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., ⋯Goodman R.R. (2001a). Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 25 , 713-728. (Pubitemid 32995954)
82. Sackeim H.A., Keilp J.G., Rush A.J., George M.S., Marangell L.B., Dormer J.S., ⋯Zboyan H. (2001b). The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14 , 53-62. (Pubitemid 32179137)
83. Sartorius A., Kiening K.L., Kirsch P., von Gall C.C., Haberkorn U., Unterberg A.W., ⋯Meyer-Lindenberg A. (2010). Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biological Psychiatry, 67 , e9-e11.
84. Schlaepfer T.E., Frick C., Zobel A., Maier W., Heuser I., Bajbouj M., O'Keane V., ⋯Hasdemir M. (2008a). Vagus nerve stimulation for depression: Efficacy and safety in a European study. Psychological Medicine, 38 , 651-661. (Pubitemid 351483238)
85. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., ⋯Sturm V. (2008b). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology, 33, 368-377. (Pubitemid 350243349)
86. Senior C. (2003). Beauty in the brain of the beholder. Neuron, 38 , 525-528. (Pubitemid 36645028)
87. Shen H., Fuchino Y., Miyamoto D., Nomura H. & Matsuki N. (2011).Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of ǎ -adrenergic receptors and the locus coeruleus. International Journal of Neuropsychopharmacology, DOI: 10.1017/S1461145711000708
88. Shuchman M. (2007). Approving the vagus-nerve stimulator for depression. New England Journal of Medicine, 356, 1604-1607. (Pubitemid 46631669)
89. Shumake J. & Gonzalez-Lima F. (2003). Brain systems underlying susceptibility to helplessness and depression. Behavior and Cognition Neuroscience Review, 2 , 198-221.
90. Souery D., Amsterdam J., de Montigny C., Lecrubier Y., Montgomery S., Lipp O., ⋯Mendlewicz J. (1999). Treatment resistant depression: Methodological overview and operational criteria. European Neuropsychopharmacology , 9, 83-91. (Pubitemid 29073687)
91. Thase M.E. & Rush A.J. (1997). When at first you don't succeed: Sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry, 58S13 , S23 - 29.
92. Velasco F., Velasco M., Jim é nez F., Velasco A.L. & Salin-Pascual R. (2005). Neurobiological background for performing surgical intervention in the inferior thalamic peduncle for treatment of major depression disorders. Neurosurgery, 57 , 439-448.
93. Velasco M., Velasco F., Jim é nez F., Carrillo-Ruiz J.D., Velasco A.L. & Sal í n-Pascual R. (2006). Electrocortical and behavioral responses elicited by acute electrical stimulation of inferior thalamic peduncle and nucleus reticularis thalami in a patient with major depression disorder. Clinical Neurophysiology, 117 , 320-327. (Pubitemid 43228022)
94. Vitek J.L. Mechanisms of deep brain stimulation: Excitation or inhibition. Movement Disorders, 17S3 , S69 - 72.
95. Warden D., Rush A.J., Trivedi M.H., Fava M. & Wisniewski S.R. (2007). The STAR * D Project results: A comprehensive review of findings. Currrent Psychiatry Reports, 9 , 449-459. (Pubitemid 350284935)
96. Zobel A., Joe A., Freymann N., Clusmann H., Schramm J., Reinhardt M., ⋯Broich K. (2005). Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach. Psychiatry Research, 139, 165-179. (Pubitemid 41116661)